Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue, net $ 2,674,000 $ 2,083,000
Cost of revenue 2,298,000 5,540,000
Gross profit (deficit) 376,000 (3,457,000)
Operating Expenses:    
Research and development 7,818,000 7,456,000
Sales and marketing 3,974,000 5,177,000
General and administrative 9,722,000 5,367,000
Total operating expenses 21,514,000 18,000,000
Loss from operations (21,138,000) (21,457,000)
Interest expense, net (1,272,000) (932,000)
Change in fair value of warrant liability (29,120,000) 4,510,000
Loss on debt extinguishment   (837,000)
Other expense, net 121,000 (1,000)
Loss before provision for income taxes (51,409,000) (18,717,000)
Provision for income taxes 0 4,000
Net loss (51,409,000) (18,721,000)
Deemed dividend on conversion of Series B preferred for common stock and repurchase of Series B preferred stock (5,842,000) (6,360,000)
Deemed dividend on issuance of common stock and warrants issued in connection with amendments to warrants to purchase common stock (10,475,000)  
Net loss attributable to common stockholders $ (67,726,000) $ (25,081,000)
Net loss per common share- basic (in dollars per share) $ (16.14) $ (476.31)
Net loss per common share- diluted (in dollars per share) $ (16.14) $ (476.31)
Weighted average number of common shares used in computing net loss per common share - Basic (in shares) 4,197,284 52,656
Weighted average number of common shares used in computing net loss per common share - Diluted (in shares) 4,197,284 52,656